Popular in Professional

Constitutional Law

What is constitutional ideology?

University of Oxford Nick Barber

Civil Procedure Law

Politics, Identity, and Class Certification on the U.S. Courts of Appeals

University of Pennsylvania Sean Farhang

Culture and Society

The City as a Growth Machine: Toward a Political Economy of Place

New York University Harvey Moltoch

Education

The Role of Education in Reducing Racial Inequality

University of Southern California Pedro A. Noguera

Law

Diversity and Social Mobility in the UK legal profession

Law Society I. Stephanie Boyce

Internet Law

The Law of AI for Good

University of San Diego Orly Lobel

Pharmacy

Cytotoxic Activity and Anti-Migratory Effect of Berberine-Phytantriol Liquid Crystalline on Non-Small-Cell Lung Cancer

University of Technology Sydney Kamal Dua

Evidence for locus coeruleus-norepinephrine system abnormality in military PTSD revealed by neuromelanin-sensitive MRI

View more insights in Professional - Medicine - Neuropsychiatric Disorders

View more figures from University of Ottawa

View the page of Clifford Cassidy

Read the Study

Next in Medicine

Seroprevalence of hepatitis B antibodies among international and domestic university students

Anita Heywood | UNSW Sydney

Environmental factors in health data reporting

Arnagretta Hunter | Australian National University

Clifford Cassidy discusses the complex neurobiology of posttraumatic stress disorder (PTSD) calls for the characterization of specific disruptions in brain functions that require targeted treatment.

Image courtesy of interviewee. May 2, 2024

Log-in or Sign-up to Faculti
Currently viewing this subject insight as a guest. You have insight(s) remaining for this month. Login to view 8000+ figures on the platform.

Generating Workspace...

Export as PDF

This video video discusses a study aimed at finding better treatments for PTSD, particularly military PTSD, which is challenging to treat. While psychotherapy is effective, it requires significant time and resources, and medications often do not work effectively for all patients. The study focuses on understanding neurotransmitter systems that may be dysregulated in individuals with PTSD, specifically examining the locus coeruleus and its relationship to the norepinephrine system.

The researcher highlights that PTSD is a heterogeneous condition, with varying symptoms among individuals. The study utilizes neuroimaging methods, particularly neuro melanin-sensitive MRI, to investigate brain activity in critical regions related to norepinephrine and dopamine. The findings indicate that veterans with PTSD exhibited higher neuro melanin signals in the locus coeruleus compared to healthy controls, suggesting increased activity in this area is linked to hyper-arousal symptoms.

Overall, the research underscores the importance of the norepinephrine system in PTSD and advocates for further exploration of individualized treatments based on identifiable chemical imbalances. It also notes the clinical application potential of the neuro melanin MRI method, which has received FDA clearance for use in diagnosing PTSD. This video video approach could lead to more effective, personalized treatment strategies for those affected by PTSD.

Language:

Export as PDF

X-TIMESTAMP-MAP:LOCAL=00:00:00.000,MPEGTS=900000

00:00.000 --> 00:01.765
There's different angles to it.

00:01.965 --> 00:04.405
I mean, I think the most important reason

00:04.405 --> 00:08.645
to do a study like this, ultimately is to, you know,

00:08.835 --> 00:11.285
kind try to find better treatments for PTSD.

00:11.385 --> 00:14.565
So, you know, PTSD is difficult to treat, especially,

00:14.745 --> 00:16.085
military PTSD.

00:16.345 --> 00:20.405
Um, and the best treatments, are psychotherapy, which,

00:20.505 --> 00:22.845
you know, work well, but they take time

00:22.865 --> 00:24.085
and they don't work for everybody

00:24.545 --> 00:26.165
and they're, you know, costly.

00:26.165 --> 00:29.045
There's a lot of resources to, to make them happen.

00:29.785 --> 00:33.685
And medications for PTSD are, you know, some, some work

00:33.705 --> 00:36.245
for some people, but they don't work as well as they might.

00:36.585 --> 00:37.965
And, and there's not a lot

00:37.965 --> 00:40.125
of dedicated medications for PTSD.

00:40.615 --> 00:42.125
Often they're u re, you know,

00:42.125 --> 00:43.805
using antidepressants basically.

00:43.945 --> 00:45.685
Um, drugs like that.

00:46.385 --> 00:49.605
So ultimately, you know, most

00:49.605 --> 00:52.165
of the psychiatric medications we use are acting on

00:52.305 --> 00:54.005
neurotransmitter receptors in the brain.

00:54.585 --> 00:57.685
So maybe, you know, by understanding better

00:57.715 --> 00:59.645
what neurotransmitter systems are,

01:00.445 --> 01:04.625
are dysregulated in PTSD, we could be in a better position

01:04.685 --> 01:06.105
to medicate it with drugs.

01:06.705 --> 01:09.705
A lot of these, you know, neurotransmitter, systems

01:09.735 --> 01:12.065
that are targeted by psychiatric drugs are called neuro

01:12.125 --> 01:15.225
neuromodulators, so they kind of amp up

01:15.405 --> 01:17.865
or dampen down brain activity.

01:18.325 --> 01:21.665
Um, so they can kind of, you know, affect people's level

01:21.725 --> 01:25.145
of arousal or mood or, or things like that.

01:25.405 --> 01:30.025
So, yeah, so that's an easy way

01:30.445 --> 01:33.345
to use a drug to manipulate the brain.

01:33.655 --> 01:35.945
That kind of leads into where I was going.

01:35.945 --> 01:39.465
Another, important point about all this is, you know,

01:39.485 --> 01:42.305
one reason a condition like PTSD is hard to treat is

01:42.305 --> 01:46.865
because, most people have a bit of a different picture.

01:47.205 --> 01:49.665
Um, so it's a pretty heterogeneous condition,

01:49.765 --> 01:51.745
and there's a different set of symptoms.

01:52.045 --> 01:53.705
Um, you don't need all the symptoms

01:54.245 --> 01:55.945
to have to have the disorder.

01:56.205 --> 01:58.625
Um, and different people have more prominent

01:58.785 --> 02:00.145
deficits in different areas.

02:00.445 --> 02:03.705
So, so, yeah,

02:04.405 --> 02:05.785
you couldn't maybe have one drug

02:05.785 --> 02:07.025
that would be like a magic bullet

02:07.025 --> 02:08.865
that would hit all the different targets for,

02:08.965 --> 02:10.305
for PTSD, for instance.

02:10.965 --> 02:14.385
Um, but you could think about certain types of symptoms

02:14.385 --> 02:17.105
that are common in PTSD that are easier to link to,

02:17.685 --> 02:19.985
you know, brain functions that you could treat.

02:20.215 --> 02:22.825
Like the, the system that we were talking about,

02:22.825 --> 02:25.665
or the symptom that we're concerned with in the study is,

02:25.685 --> 02:28.985
is hyper arousal, which is a pretty easy,

02:28.985 --> 02:30.025
symptom to relate to.

02:30.185 --> 02:32.705
I think most people have had some kind

02:32.705 --> 02:36.345
of low level experience of, of hyper arousal.

02:36.405 --> 02:39.465
Um, so you can think of it as,

02:40.185 --> 02:43.825
elevated vigilance like watchfulness or fearful, long

02:43.825 --> 02:45.025
after a threat has passed.

02:45.285 --> 02:47.825
So people have trouble relaxing

02:48.125 --> 02:51.425
and calming down, even if, you know,

02:51.425 --> 02:53.465
they're in a safe environment, cut into people's quality

02:53.465 --> 02:57.665
of life and make it not, yeah, that's a lot

02:57.665 --> 02:58.665
of negative consequences.

02:59.305 --> 03:02.165
So that's, you know, where I come at it as a researcher,

03:02.185 --> 03:04.685
you know, it's hard sometimes to,

03:05.945 --> 03:07.045
to think about the big picture,

03:07.585 --> 03:11.665
and usually you start out with the methods

03:11.695 --> 03:12.825
that you have strength in

03:12.885 --> 03:14.825
and finding relevant applications for them.

03:14.885 --> 03:19.065
So a lot of my recent work has been about developing a

03:19.065 --> 03:22.145
certain neuroimaging method and making it better,

03:22.685 --> 03:25.545
and at the same time finding new applications for it

03:25.635 --> 03:26.985
where it could be most useful.

03:27.525 --> 03:30.025
So that's definitely, you know, a big part of

03:30.025 --> 03:33.185
what this study was about is, is working on these methods.

03:33.285 --> 03:36.945
So there's, neuroimaging method that has been around

03:36.945 --> 03:40.395
for a while, but, you know, we've done a lot of work to,

03:41.015 --> 03:44.915
to improve it and to show how it can be used in different,

03:44.915 --> 03:46.395
different types of applications.

03:46.455 --> 03:50.115
So this method is called neuro melanin sensitive, MRI,

03:50.615 --> 03:53.035
so it's a very specific method

03:53.035 --> 03:57.275
because it only can look at two brain regions,

03:57.975 --> 03:59.915
so it doesn't even scan the full brain,

04:00.655 --> 04:03.275
but those two brain regions are extremely important

04:03.295 --> 04:05.875
for many, neuropsychiatric conditions.

04:05.935 --> 04:08.915
So there's the locus aurelius, which is the, you know,

04:08.985 --> 04:10.035
subject of this study,

04:10.055 --> 04:12.915
and that's kind of like the heart of the norepinephrine

04:13.175 --> 04:15.915
or the noradrenergic, same thing,

04:15.975 --> 04:17.075
neurotransmitter system.

04:17.535 --> 04:19.235
And then there's also the substantial nigra,

04:19.235 --> 04:21.275
which is the heart of the dopamine,

04:21.575 --> 04:22.635
neurotransmitter system.

04:22.655 --> 04:24.515
And a lot of the work we've done has also been

04:24.515 --> 04:25.675
in the substantial nigra.

04:26.495 --> 04:31.415
But, so, so these two brain regions are,

04:32.805 --> 04:35.345
are important for so many brain functions

04:35.345 --> 04:37.705
and so many different, psychiatric conditions

04:37.765 --> 04:39.545
and also neurological conditions.

04:39.805 --> 04:43.745
So even though we only looking at two very specific regions,

04:43.745 --> 04:45.305
they are important for almost all

04:45.365 --> 04:46.905
of psychiatry one way or another.

04:47.685 --> 04:52.545
Um, so for, for this study,

04:52.555 --> 04:54.105
we're looking at the locus aurelius

04:54.945 --> 04:59.695
and, in general, these,

04:59.765 --> 05:03.455
this imaging method is able, so

05:04.515 --> 05:09.335
the subtlety to it is, it's, it's sensitive to this,

05:09.405 --> 05:11.775
this brain chemical called neuro melanin,

05:11.785 --> 05:14.135
which is only found in those two regions of the brain,

05:14.155 --> 05:16.615
the locus aurelius and the sub substain nigra.

05:17.395 --> 05:21.595
And the idea is you're born without any neuro melanin,

05:21.935 --> 05:24.475
and it gradually accumulates over the lifespan

05:24.475 --> 05:27.595
and just builds up inside the neuron cell bodies in those

05:27.615 --> 05:28.675
two brain regions.

05:29.615 --> 05:33.265
And, it's actually visible to the human eye.

05:33.265 --> 05:35.945
So that's why those regions, have the names.

05:35.945 --> 05:37.945
They do that substantial nigra is black

05:37.945 --> 05:40.425
because it has this black pigment neuro melanin in it.

05:40.685 --> 05:42.945
And the locus aurelius is bluish aurelius

05:43.175 --> 05:44.545
because of the same pigment.

05:44.845 --> 05:49.815
Um, so the idea is that it's a marker

05:50.035 --> 05:51.735
of if the cells are there or not.

05:51.995 --> 05:53.935
If that pigment's there, it means the cell is there.

05:54.075 --> 05:56.735
The only way to get rid of that pigment is if the cell dies.

05:56.735 --> 05:58.285
It just builds up gradually

05:58.285 --> 06:00.245
and it can't be destroyed unless the cell dies.

06:01.185 --> 06:05.685
So the, this method, this imaging method started out

06:05.685 --> 06:08.165
as a marker of neurodegeneration of those structures.

06:08.825 --> 06:11.725
So it was used a lot in Parkinson's disease to see the death

06:11.725 --> 06:12.805
of the dopamine neurons

06:13.225 --> 06:15.125
and in Alzheimer's disease to see the death

06:15.125 --> 06:16.645
of the locus s neuros.

06:16.865 --> 06:18.405
And we did work in Alzheimer's also.

06:19.105 --> 06:22.205
So that's where this, you know, the, the

06:23.925 --> 06:28.275
basic, work started for neuro melanin sensitive MRI,

06:28.865 --> 06:31.605
but then bringing it from research

06:31.605 --> 06:33.525
and neurodegeneration to research

06:33.525 --> 06:36.805
and psychiatry where it, these cells aren't dying,

06:36.905 --> 06:37.925
or even healthy people.

06:38.715 --> 06:41.505
That's kind of the leap that our group

06:41.725 --> 06:44.665
and our collaborators have made a big push on.

06:45.285 --> 06:47.985
So, so we're saying

06:47.985 --> 06:50.545
that even when the cells aren't dying, the amount

06:50.605 --> 06:53.705
of neuro mein and neuro mein, MRI signal

06:54.245 --> 06:57.065
is telling you something about how active these cells are.

06:57.885 --> 07:00.785
So, you know, there's this idea of an imbalance, a

07:01.465 --> 07:02.865
chemical imbalance in psychiatry

07:02.865 --> 07:05.585
that psychiatrists will tell their patients they have a

07:05.745 --> 07:08.465
chemical imbalance and you know, it's an oversimplification,

07:08.525 --> 07:12.185
but a method like this can, can tap into that.

07:12.325 --> 07:15.865
We can see if there's excess signal in this locus aerius,

07:16.495 --> 07:17.865
it's perhaps due

07:17.865 --> 07:20.705
to this chemical imbalance in the norepinephrine system.

07:21.165 --> 07:22.825
It may not be just PTSD,

07:22.825 --> 07:25.705
but if you know more directly to this hyper arousal idea,

07:25.845 --> 07:28.065
so veterans with hyper arousal, it,

07:28.065 --> 07:31.225
that hyper arousal could be due to excess activity

07:31.245 --> 07:34.065
of this locus, aurelius norepinephrine system.

07:34.885 --> 07:37.785
So, so yeah, that's, that,

07:37.785 --> 07:40.465
that excess activity would mean this neurotransmitters being

07:40.705 --> 07:42.385
released too much, it's cycling around

07:42.405 --> 07:44.505
and every time it cycles it's released

07:44.505 --> 07:46.065
and then it's taken back up into the cell.

07:46.525 --> 07:49.185
It can lead to more of this norm neuro mein formation.

07:49.285 --> 07:51.025
And over the span of months

07:51.045 --> 07:53.745
and years that we could maybe detect that with,

07:53.775 --> 07:56.545
with this MRI sequence it there,

07:56.605 --> 07:58.985
we had basically two, two main findings.

07:59.045 --> 08:03.465
So we had a group of military veterans with PTSD

08:03.485 --> 08:06.065
who had served in Afghanistan in the Canadian armed forces.

08:06.965 --> 08:11.485
Um, so we had I think, 34 of them.

08:12.305 --> 08:16.045
And we also had a group of healthy controls

08:16.065 --> 08:18.725
who didn't have any psychiatric history.

08:18.865 --> 08:19.965
We had 32 of them,

08:21.625 --> 08:24.765
and everybody was, was scanned in the MRI

08:24.765 --> 08:26.805
to get this neuro melanin sensitive,

08:27.285 --> 08:29.565
MRI signal in the locus aurelius.

08:30.185 --> 08:31.885
And we found that as a whole, the people

08:31.885 --> 08:33.885
with PTSD had higher signal

08:34.425 --> 08:36.445
in the locus aurelius than the controls.

08:37.185 --> 08:39.685
So it was suggesting that, you know,

08:39.685 --> 08:42.885
that this system in general is more active in PTSD.

08:43.625 --> 08:46.325
Now, it wasn't active, it wasn't higher in every single

08:46.325 --> 08:48.885
person with PTSD compared to the controls.

08:49.545 --> 08:52.205
So, you know, that also is consistent with the idea

08:52.205 --> 08:54.765
that maybe this isn't a problem for every person with ptsd

08:55.045 --> 08:56.485
SD, but if you take them

08:56.485 --> 08:58.125
as a group on average, they're higher.

08:58.925 --> 09:03.065
Um, and so, you know, we thought that what type of person

09:03.065 --> 09:05.425
with PTSD would be most likely

09:05.485 --> 09:08.905
to have elevated neuro melanin signal in the locus Aurelius,

09:09.205 --> 09:10.305
we thought it would be those people

09:10.305 --> 09:12.185
that have these hyper arousal symptoms.

09:12.845 --> 09:15.665
So we looked within that group of people with PTSD,

09:16.085 --> 09:17.145
and we found that the people

09:17.145 --> 09:20.065
that had a higher locus really signal were indeed the ones

09:20.065 --> 09:21.865
who had more hyper arousal symptoms.

09:22.325 --> 09:25.145
The convenient thing in our case is that if you, you know,

09:25.145 --> 09:27.745
look up on Wikipedia, the norepinephrine system

09:27.805 --> 09:30.385
or sometimes called the noradrenergic system in, in Britain,

09:31.045 --> 09:34.475
the first thing it'll tell you about the functions of

09:34.475 --> 09:37.835
that system, it'll will be, it regulates level of arousal.

09:38.135 --> 09:40.675
So when you're sleeping, the system is totally quiet,

09:41.535 --> 09:44.275
and if you are, if someone's chasing you with a knife,

09:44.305 --> 09:45.955
then it's gonna be going in overdrive.

09:46.255 --> 09:48.115
So most of the time we're somewhere in

09:48.115 --> 09:50.755
between on those levels of, of arousal.

09:51.375 --> 09:56.025
Um, so, so you know, there's a,

09:56.025 --> 09:58.585
there's a strong theoretical reason why this system would be

09:58.785 --> 10:02.065
relevant for this behavior and then in how that leads

10:02.065 --> 10:04.385
to an MRI as something we could measure with MRI.

10:04.965 --> 10:09.105
Um, the idea is if these neurons are firing more often, then

10:09.615 --> 10:11.865
this neuro melanin pigment is,

10:12.005 --> 10:14.865
is depositing more readily into the,

10:15.005 --> 10:16.865
the cell bodies in the locus Aurelius

10:17.045 --> 10:20.065
and the more neuro melanin present, you know, at some point,

10:20.065 --> 10:22.025
if there's enough of a difference, it'll,

10:22.125 --> 10:23.905
the MRI is sensitive enough to see it

10:24.045 --> 10:25.785
and we can tell that, you know,

10:26.535 --> 10:28.345
that person has an elevated signal.

10:29.015 --> 10:31.025
Yeah. So I think, you know, there's two branches

10:31.025 --> 10:33.465
of conclusions, one that's more relevant to the methods.

10:34.005 --> 10:36.785
Um, but I'll start with the, the broader conclusions

10:36.785 --> 10:38.665
that are relevant for people with PTSD.

10:39.245 --> 10:40.465
Um, and,

10:40.565 --> 10:42.985
and that is highlighting the relevance

10:42.985 --> 10:46.625
of the norepinephrine system to PTSD symptoms.

10:47.165 --> 10:48.545
And there's certainly plenty of research

10:48.545 --> 10:50.625
that's been done on that in the past.

10:51.005 --> 10:52.145
Um, you know,

10:52.195 --> 10:56.065
using different methods like even animal models of of PTSD,

10:56.605 --> 10:58.505
but also human studies.

10:59.565 --> 11:01.875
So, you know, there is quite a bit of research,

11:01.875 --> 11:04.475
but at the same time, if you read a review about PTSD,

11:04.475 --> 11:05.715
it may not even be mentioned.

11:05.715 --> 11:06.835
Like there's a lot of theories

11:06.835 --> 11:10.395
and a lot of other I models of PTSD, TSD out there as well.

11:11.055 --> 11:13.795
So I think, you know, it's, it's lobbying

11:13.795 --> 11:16.475
for more attention on the role of the norepinephrine system,

11:16.475 --> 11:20.435
especially in these particular, behaviors in P ts D

11:21.255 --> 11:23.715
and in turn that matters

11:23.715 --> 11:27.875
because chemicals can, can give a very direct link

11:27.895 --> 11:29.435
to drug treatments, right?

11:29.575 --> 11:32.355
So studying brain chemicals is different than

11:32.555 --> 11:33.795
studying, you know, brain activity.

11:33.855 --> 11:34.875
It may be harder to know

11:34.875 --> 11:36.195
how you would change brain activity,

11:36.295 --> 11:38.075
but if you see that there's a chemical imbalance,

11:38.075 --> 11:40.275
you can give a drug that can rank,

11:40.275 --> 11:41.395
remedy that imbalance.

11:42.215 --> 11:46.115
And indeed there is a drug that's been used in PTSD,

11:46.345 --> 11:48.755
with mixed results called prazocin,

11:48.965 --> 11:51.915
which blocks the norepinephrine system activity.

11:52.695 --> 11:56.905
Um, and I think, you know, there could be more work on

11:56.905 --> 11:59.105
that drug or maybe similar types of drugs.

11:59.685 --> 12:02.945
And maybe part of the reason it's had this mixed evidence,

12:02.945 --> 12:05.505
some studies showing that razin works, especially

12:05.505 --> 12:06.985
for nightmares in PTSD.

12:07.525 --> 12:09.585
Um, there's a whole other story about nightmares in the

12:09.585 --> 12:13.645
norepinephrine system, but, some studies show

12:13.645 --> 12:16.165
that it didn't work, and it could be that if you were

12:16.165 --> 12:17.165
to prescreen people

12:17.905 --> 12:20.845
and see who actually has an imbalance in the norepinephrine

12:20.845 --> 12:23.085
system using a method like this imaging scan,

12:23.875 --> 12:26.375
you might be more likely to get a good response to the drug.

12:26.435 --> 12:29.815
So it's kind of moving towards this idea of individualized

12:30.375 --> 12:34.095
medicine, by, you know, finding a biomarker

12:34.165 --> 12:36.255
that could predict who would be likely

12:36.275 --> 12:37.415
to respond to a treatment.

12:37.475 --> 12:39.735
You know, that would be something with collaborators in,

12:40.075 --> 12:42.215
you know, due to clinical clinical studies,

12:42.275 --> 12:43.335
we could follow up on that.

12:43.755 --> 12:46.415
But I would say, just as an aside that this method

12:46.415 --> 12:49.465
that we're talking about, the neuro melanin, MRI,

12:49.635 --> 12:53.305
we've had a bit of a, an experience about how, you know,

12:53.305 --> 12:55.865
we just talk about bringing ideas from science

12:55.885 --> 12:58.705
to the clinic, but in our case, we actually did partner

12:58.815 --> 13:00.705
with an industry, partner.

13:01.485 --> 13:05.425
And now the, the neuro melanin, MRI has been FDA cleared

13:05.485 --> 13:06.985
to be used, clinically.

13:07.205 --> 13:11.185
So, you know, to be used for the indication of PTSD,

13:11.185 --> 13:13.705
that would be, you know, more steps down the road.

13:13.845 --> 13:16.425
But at least in principle, the method can be used now.

Advancing Treatments for PTSD Challenges

00:00:00 - There's different angles to it. I mean, I think the most important reason to do a study like this, ultimately is to, you know, kind try to find better treatments for PTSD. So, you know, PTSD is difficult to treat, especially, military PTSD. and the best treatments, are psychotherapy, which, you know, work well, but they take time and they don't work for everybody and they're, you know, costly. There's a lot of resources to, to make them happen. And medications for PTSD are, you know, some, some work
00:00:36 - And, and there's not a lot of dedicated medications for PTSD. Often they're u re, you know, using antidepressants basically. drugs like that. So ultimately, you know, most of the psychiatric medications we use are acting on neurotransmitter receptors in the brain. So maybe, you know, by understanding better what neurotransmitter systems are, are dysregulated in PTSD, we could be in a better position
00:01:06 - A lot of these, you know, neurotransmitter, systems that are targeted by psychiatric drugs are called neuro neuromodulators, so they kind of amp up or dampen down brain activity. so they can kind of, you know, affect people's level of arousal or mood or, or things like that. So, yeah, so that's an easy way to use a drug to manipulate the brain. That kind of leads into where I was going.
00:01:39 - one reason a condition like PTSD is hard to treat is because, most people have a bit of a different picture. so it's a pretty heterogeneous condition, and there's a different set of symptoms. you don't need all the symptoms to have to have the disorder. and different people have more prominent deficits in different areas. So, so, yeah, you couldn't maybe have one drug that would be like a magic bullet
00:02:08 - for PTSD, for instance. but you could think about certain types of symptoms that are common in PTSD that are easier to link to, you know, brain functions that you could treat. Like the, the system that we were talking about, or the symptom that we're concerned with in the study is, is hyper arousal, which is a pretty easy, symptom to relate to. I think most people have had some kind of low level experience of, of hyper arousal. so you can think of it as,
00:02:43 - after a threat has passed. So people have trouble relaxing and calming down, even if, you know, they're in a safe environment, cut into people's quality of life and make it not, yeah, that's a lot of negative consequences. So that's, you know, where I come at it as a researcher, you know, it's hard sometimes to, to think about the big picture, and usually you start out with the methods

Advancements in Neuro Melanin Sensitive MRI

00:03:12 - and finding relevant applications for them. So a lot of my recent work has been about developing a certain neuroimaging method and making it better, and at the same time finding new applications for it where it could be most useful. So that's definitely, you know, a big part of what this study was about is, is working on these methods. So there's, neuroimaging method that has been around for a while, but, you know, we've done a lot of work to, to improve it and to show how it can be used in different,
00:03:46 - So this method is called neuro melanin sensitive, MRI, so it's a very specific method because it only can look at two brain regions, so it doesn't even scan the full brain, but those two brain regions are extremely important for many, neuropsychiatric conditions. So there's the locus aurelius, which is the, you know, subject of this study, and that's kind of like the heart of the norepinephrine or the noradrenergic, same thing,
00:04:17 - And then there's also the substantial nigra, which is the heart of the dopamine, neurotransmitter system. And a lot of the work we've done has also been in the substantial nigra. But, so, so these two brain regions are, are important for so many brain functions and so many different, psychiatric conditions and also neurological conditions. So even though we only looking at two very specific regions, they are important for almost all of psychiatry one way or another.
00:04:52 - we're looking at the locus aurelius and, in general, these, this imaging method is able, so the subtlety to it is, it's, it's sensitive to this, this brain chemical called neuro melanin, which is only found in those two regions of the brain, the locus aurelius and the sub substain nigra. And the idea is you're born without any neuro melanin,
00:05:24 - and just builds up inside the neuron cell bodies in those two brain regions. And, it's actually visible to the human eye. So that's why those regions, have the names. They do that substantial nigra is black because it has this black pigment neuro melanin in it. And the locus aurelius is bluish aurelius because of the same pigment. so the idea is that it's a marker of if the cells are there or not.
00:05:54 - The only way to get rid of that pigment is if the cell dies. It just builds up gradually and it can't be destroyed unless the cell dies. So the, this method, this imaging method started out as a marker of neurodegeneration of those structures. So it was used a lot in Parkinson's disease to see the death of the dopamine neurons and in Alzheimer's disease to see the death of the locus s neuros. And we did work in Alzheimer's also. So that's where this, you know, the, the

Neuroimaging Insights into PTSD and Norepinephrine

00:06:28 - but then bringing it from research and neurodegeneration to research and psychiatry where it, these cells aren't dying, or even healthy people. That's kind of the leap that our group and our collaborators have made a big push on. So, so we're saying that even when the cells aren't dying, the amount of neuro mein and neuro mein, MRI signal
00:06:57 - So, you know, there's this idea of an imbalance, a chemical imbalance in psychiatry that psychiatrists will tell their patients they have a chemical imbalance and you know, it's an oversimplification, but a method like this can, can tap into that. We can see if there's excess signal in this locus aerius, it's perhaps due to this chemical imbalance in the norepinephrine system. It may not be just PTSD, but if you know more directly to this hyper arousal idea,
00:07:28 - that hyper arousal could be due to excess activity of this locus, aurelius norepinephrine system. So, so yeah, that's, that, that excess activity would mean this neurotransmitters being released too much, it's cycling around and every time it cycles it's released and then it's taken back up into the cell. It can lead to more of this norm neuro mein formation. And over the span of months and years that we could maybe detect that with, with this MRI sequence it there,
00:07:59 - So we had a group of military veterans with PTSD who had served in Afghanistan in the Canadian armed forces. so we had I think, 34 of them. And we also had a group of healthy controls who didn't have any psychiatric history. We had 32 of them, and everybody was, was scanned in the MRI to get this neuro melanin sensitive,
00:08:30 - And we found that as a whole, the people with PTSD had higher signal in the locus aurelius than the controls. So it was suggesting that, you know, that this system in general is more active in PTSD. Now, it wasn't active, it wasn't higher in every single person with PTSD compared to the controls. So, you know, that also is consistent with the idea that maybe this isn't a problem for every person with ptsd SD, but if you take them as a group on average, they're higher.
00:09:03 - with PTSD would be most likely to have elevated neuro melanin signal in the locus Aurelius, we thought it would be those people that have these hyper arousal symptoms. So we looked within that group of people with PTSD, and we found that the people that had a higher locus really signal were indeed the ones who had more hyper arousal symptoms. The convenient thing in our case is that if you, you know, look up on Wikipedia, the norepinephrine system or sometimes called the noradrenergic system in, in Britain,

Understanding Arousal in PTSD Treatment

00:09:34 - that system, it'll will be, it regulates level of arousal. So when you're sleeping, the system is totally quiet, and if you are, if someone's chasing you with a knife, then it's gonna be going in overdrive. So most of the time we're somewhere in between on those levels of, of arousal. so, so you know, there's a, there's a strong theoretical reason why this system would be relevant for this behavior and then in how that leads
00:10:04 - the idea is if these neurons are firing more often, then this neuro melanin pigment is, is depositing more readily into the, the cell bodies in the locus Aurelius and the more neuro melanin present, you know, at some point, if there's enough of a difference, it'll, the MRI is sensitive enough to see it and we can tell that, you know, that person has an elevated signal. Yeah. So I think, you know, there's two branches of conclusions, one that's more relevant to the methods.
00:10:36 - that are relevant for people with PTSD. and, and that is highlighting the relevance of the norepinephrine system to PTSD symptoms. And there's certainly plenty of research that's been done on that in the past. you know, using different methods like even animal models of of PTSD, but also human studies. So, you know, there is quite a bit of research, but at the same time, if you read a review about PTSD,
00:11:05 - Like there's a lot of theories and a lot of other I models of PTSD, TSD out there as well. So I think, you know, it's, it's lobbying for more attention on the role of the norepinephrine system, especially in these particular, behaviors in P ts D and in turn that matters because chemicals can, can give a very direct link to drug treatments, right? So studying brain chemicals is different than studying, you know, brain activity. It may be harder to know
00:11:36 - but if you see that there's a chemical imbalance, you can give a drug that can rank, remedy that imbalance. And indeed there is a drug that's been used in PTSD, with mixed results called prazocin, which blocks the norepinephrine system activity. and I think, you know, there could be more work on that drug or maybe similar types of drugs. And maybe part of the reason it's had this mixed evidence, some studies showing that razin works, especially
00:12:07 - there's a whole other story about nightmares in the norepinephrine system, but, some studies show that it didn't work, and it could be that if you were to prescreen people and see who actually has an imbalance in the norepinephrine system using a method like this imaging scan, you might be more likely to get a good response to the drug. So it's kind of moving towards this idea of individualized medicine, by, you know, finding a biomarker that could predict who would be likely

Neuro Melanin MRI Receives FDA Clearance

00:12:37 - You know, that would be something with collaborators in, you know, due to clinical clinical studies, we could follow up on that. But I would say, just as an aside that this method that we're talking about, the neuro melanin, MRI, we've had a bit of a, an experience about how, you know, we just talk about bringing ideas from science to the clinic, but in our case, we actually did partner with an industry, partner. And now the, the neuro melanin, MRI has been FDA cleared to be used, clinically.
00:13:13 - that would be, you know, more steps down the road. But at least in principle, the method can be used now.

Faculti AI can make mistakes

Faculti

Popular in Professional

What is constitutional ideology?

Politics, Identity, and Class Certification on the U.S. Courts of Appeals

The City as a Growth Machine: Toward a Political Economy of Place

The Role of Education in Reducing Racial Inequality

The Law of AI for Good

Cytotoxic Activity and Anti-Migratory Effect of Berberine-Phytantriol Liquid Crystalline on Non-Small-Cell Lung Cancer

Evidence for locus coeruleus-norepinephrine system abnormality in military PTSD revealed by neuromelanin-sensitive MRI

Next in Medicine

Guide

Platform and Category Pages

Contact Us

FAQs

What is Faculti?

How do you select interviews?

Interview Process

Page Structure

Popular in Professional

Guide

Platform and Category Pages

Contact Us

FAQs

What is Faculti?

How do you select interviews?

Interview Process

Accessibility Options

Contrast Adjustment

Text Size Adjustment

Text Spacing Adjustment

Line Height Adjustment

Cursor Size Adjustment

Page Structure Options

Page Structure